Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 19;15(5):103751.
doi: 10.5498/wjp.v15.i5.103751.

Gut-brain connection in schizophrenia: A narrative review

Affiliations
Review

Gut-brain connection in schizophrenia: A narrative review

Asma Iqbal et al. World J Psychiatry. .

Abstract

Schizophrenia is a complex neuropsychiatric disorder characterized by cognitive, emotional, and behavioral impairments. The microbiota-gut-brain axis is crucial in its pathophysiology, mediating communication between the gut and brain through neural, immune, endocrine, and metabolic pathways. Dysbiosis, or an imbalance in gut microbiota, is linked to neuroinflammation, systemic inflammation, and neurotransmitter disruptions, all of which contribute to the symptoms of schizophrenia. Gut microbiota-derived metabolites, such as short-chain fatty acids, influence brain function, including immune responses and neurotransmitter synthesis. These findings suggest that microbial imbalances exacerbate schizophrenia, providing a novel perspective on the disorder's underlying mechanisms. Emerging microbiota-targeted therapies-such as probiotics, prebiotics, dietary interventions, and fecal microbiota transplantation-show promise as adjunctive treatments, aiming to restore microbial balance and improve clinical outcomes. While further research is needed, targeting the microbiota-gut-brain axis offers an innovative approach to schizophrenia management, with the potential to enhance patient outcomes and quality of life.

Keywords: Gut-brain axis; Microbiota; Neuroinflammation; Probiotics; Schizophrenia.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Figures

Figure 1
Figure 1
Gut-brain axis and roles of the vagus nerve and the enteric nervous system in brain function and their relevance to schizophrenia. The vagus nerve regulates feeding and autonomic nervous system activity and transmits gut-derived signals to the brain, influencing mood and cognition. The enteric nervous system controls local gut function, modulates immune interactions, and communicates with the brain while mediating microbiota interactions. Disruptions in these pathways, including altered gut-brain signaling, immune activation, and microbiota imbalances, have been linked to neuropsychiatric disorders such as schizophrenia and autism spectrum disorder. GI: Gastrointestinal; ASD: Autism spectrum disorder.
Figure 2
Figure 2
Tryptophan metabolism. Tryptophan can be metabolized into serotonin or kynurenine (this process is influenced by gut microbiota and inflammation/stress). Inflammation or stress shifts tryptophan metabolism toward the kynurenine pathway. Serotonin helps in mood regulation, sleep cycle, and cognitive function. Quinolinic acid is a neurotoxin, while kynurenic acid is neuroprotective.

References

    1. Ebert A, Bär KJ. Emil Kraepelin: A pioneer of scientific understanding of psychiatry and psychopharmacology. Indian J Psychiatry. 2010;52:191–192. - PMC - PubMed
    1. Javitt DC. Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment. Annu Rev Pharmacol Toxicol. 2023;63:119–141. - PubMed
    1. Góralczyk-Bińkowska A, Szmajda-Krygier D, Kozłowska E. The Microbiota-Gut-Brain Axis in Psychiatric Disorders. Int J Mol Sci. 2022;23:11245. - PMC - PubMed
    1. Gulas E, Wysiadecki G, Strzelecki D, Gawlik-Kotelnicka O, Polguj M. Can microbiology affect psychiatry? A link between gut microbiota and psychiatric disorders. Psychiatr Pol. 2018;52:1023–1039. - PubMed
    1. Severance EG, Gressitt KL, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CLG, Adamos MB, Sweeney KM, Origoni AE, Khushalani S, Dickerson FB, Yolken RH. Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study. Brain Behav Immun. 2017;62:41–45. - PMC - PubMed

LinkOut - more resources